
Opinion|Videos|October 31, 2024
Evaluating Treatment Failure and Symptomatic Remission in MDD
Key Takeaways
Experts in the management of mood disorders discuss the challenges of treatment failure and achieving symptomatic remission in MDD. They examine the efficacy of antidepressant and rapid-acting treatments, offering insights into evaluating and enhancing treatment outcomes.
Advertisement
Episodes in this series

Newsletter
Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
FDA Approves ProlivRX: First Prescription, Physician-Directed, At-Home Brain Neuromodulation Therapy for MDD
2
What Makes It So Special? A Review of the Mechanisms of Action of Lamotrigine, Carbamazepine, and Valproic Acid and How They Differ From Other Antiepileptics
3
Anticholinergic Burden and Its Effect on Cognition in Psychosis
4
In Memoriam: The Many Faces of Psychiatrists and Psychiatry
5















